郭蓉，2018年毕业于新黄金城667733华西药学院药学专业，获理学学士学位。同年保送至新黄金城667733华西药学院药剂学专业，并于2023年毕业，获理学博士学位。然后在新黄金城667733任助理研究员，专职博士后。目前主要的研究方向为肿瘤转移的发生机制及调控。参与国家自然科学基金面上项目和四川省科技厅重点项目的研究。先后发表SCI论文16篇。

从事生物分子基础实验的课程教学工作

1. Rong Guo, Miao Deng, Jiaxin Li, Xuan He, Penghui He, Houqin Liu, Yunxia Ye, Ziyi Mo, Xuan He, Man Li, Qin He. Depriving tumor cells of ways to metastasize: Ferroptosis nanotherapy blocks both hematogenous metastasis and lymphatic metastasis[J]. Nano Letters, 2023, 23(8):3401-3411.

2. Rong Guo, Miao Deng, Mengmeng Li, Jiaxin Li, Penghui He, Man Li, Zhirong Zhang, Qin He. Fucoidan-functionalized activated platelets-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment[J]. Acta Pharmaceutica Sinica B, 2022, 12(1):467-482.

3. Rong Guo*, Yang Long*, Zhengze Lu, Miao Deng, Penghui He, Man Li, Qin He. Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS[J]. Acta Pharmaceutica Sinica B, 2020, 10(10):1977-1988.

4. Miao Deng, Rong Guo, Shuya Zang, Jingdong Rao, Mengmeng Li, Xian Tang, Chunyu Xia, Man Li, Zhirong Zhang, Qin He. pH-triggered copper-free click reaction mediated micelle aggregation for enhanced tumor retention and elevated immuno-chemotherapy against melanoma[J]. ACS Applied Materials Interfaces, 2021, 13(15):18033-18046.

5. Mengmeng Li, Rong Guo, Jiaojie Wei, Miao Deng, Jiaxin Li, Yuan Tao, Man Li, Qin He. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence[J]. Acta Biomateralia, 2021, 136:546-557.

6. Jiaxin Li, Yang Long, Rong Guo, Kebai Ren, Zhengze Lu, Man Li, Xuhui Wang, Jiaxin Li, Yashi Wang, Zhirong Zhang, Qin He. Shield and sword nano-soldiers ameliorate rheumatoid arthritis by multi-stage manipulation of neutrophils[J]. Journal of Controlled Release, 2021, 335:38-48.

7. Jiaojie Wei, Yang Long, Rong Guo, Xinlei Liu, Xian Tang, Jingdong Rao, Sheng Yin, Zhirong Zhang, Man Li, Qin He. Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer[J]. Acta Pharmaceutica Sinica B, 2019, 9(4):819-831.